<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001627642</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001657312</issuerCik>
            <issuerName>Verona Pharma plc</issuerName>
            <secFileNumber>001-38067</secFileNumber>
            <issuerAddress>
                <ns2:street1>3 MORE LONDON RIVERSIDE</ns2:street1>
                <ns2:city>London</ns2:city>
                <ns2:stateOrCountry>X0</ns2:stateOrCountry>
                <ns2:zipCode>SE12RE</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>442032834200</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>DAVID ZACCARDELLI</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>50000</noOfUnitsSold>
            <aggregateMarketValue>3613000.00</aggregateMarketValue>
            <noOfUnitsOutstanding>85132003</noOfUnitsOutstanding>
            <approxSaleDate>05/02/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <acquiredDate>05/01/2021</acquiredDate>
            <natureOfAcquisitionTransaction>Restricted Stock Units</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>50000</amountOfSecuritiesAcquired>
            <paymentDate>05/01/2021</paymentDate>
            <natureOfPayment>N/A</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>DAVID ZACCARDELLI</name>
                <address>
                    <ns2:street1>3 MORE LONDON RIVERSIDE</ns2:street1>
                    <ns2:city>London</ns2:city>
                    <ns2:stateOrCountry>X0</ns2:stateOrCountry>
                    <ns2:zipCode>SE12RE</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <saleDate>04/29/2025</saleDate>
            <amountOfSecuritiesSold>90360</amountOfSecuritiesSold>
            <grossProceeds>811432.80</grossProceeds>
        </securitiesSoldInPast3Months>
        <remarks>The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/01/2021 through 11/01/2021
</remarks>
        <noticeSignature>
            <noticeDate>05/02/2025</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>01/29/2025</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ David Zaccardelli</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4230}]
144
0001627642
XXXXXXXX
LIVE
0001657312
Verona Pharma plc
001-38067
3 MORE LONDON RIVERSIDE
London
X0
SE12RE
442032834200
DAVID ZACCARDELLI
Director
Officer
ADS
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
50000
3613000.00
85132003
05/02/2025
NASDAQ
ADS
05/01/2021
Restricted Stock Units
Issuer
N
50000
05/01/2021
N/A
N
DAVID ZACCARDELLI
3 MORE LONDON RIVERSIDE
London
X0
SE12RE
ADS
04/29/2025
90360
811432.80
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/01/2021 through 11/01/2021
05/02/2025
01/29/2025
/s/ David Zaccardelli